Asset Details
Do you wish to reserve the book?
Bromodomain inhibitors a decade later: a promise unfulfilled?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bromodomain inhibitors a decade later: a promise unfulfilled?
Do you wish to request the book?
Bromodomain inhibitors a decade later: a promise unfulfilled?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Bromodomain inhibitors a decade later: a promise unfulfilled?
2020
Overview
Summary
Over the last decade, bromodomain inhibitors have emerged as a promising class of anticancer drugs. However, the clinical progress of these agents has faced significant obstacles, which precluded their regulatory approval. This editorial will review the challenges and opportunities associated with the development of bromodomain inhibitors.
Publisher
Nature Publishing Group UK,Nature Publishing Group
